‘Faces of Marijuana Prohibition’ Event Held on Capitol Hill

Generic 20 April 2017 | 0 Comments

NORML held a ‘Faces of Marijuana Prohibition’ event on Capitol Hill on April 19th, in cooperation with the Congressional Cannabis Caucus, where congressional staff heard first-hand from those most adversely impacted by the criminalization of marijuana. 

Dozens of congressional staff attended, hearing from victims across the spectrum of marijuana criminalization. Perspectives included: a cancer survivor who consumed marijuana to mitigate the effects of chemotherapy, a federal staffer who lost his job as a result of a positive drug test, and those who received criminal charges and had their lives put on hold while they had to overcome the onerous penalties imposed by the state for a simple possession charge, among others. 

NORML Political Director Justin StrekalThis was yet another effort in our ongoing quest to educate our legislators on the need to to end the prohibition-industrial-complex and respect the basic rights of those who choose to consume marijuana, a substance safer than currently legal products like alcohol or cigarettes.

Never in modern history has there existed greater public support for ending the nation’s nearly century-long experiment with marijuana prohibition. The continued criminalization of adult marijuana users is out-of-step with the views of adults throughout America, 93% of whom support medical marijuana (Quinnipiac, 2017) and 60 percent of whom endorse the outright legalization of recreational marijuana (Gallup, 2016).

On April 20th (4/20), long considered the unofficial marijuana holiday, marijuana consumers and advocates will gather around the world to show their support for ending marijuana prohibition. NORML for its part will hosting an online day of action, driving tens of thousands of constituent contacts to members of Congress in support of HR 1227, the Ending Federal Marijuana Prohibition Act. 

You can sign up for the 4/20 online day of action by clicking here. 

Tagged in , , ,

Leave a Reply